Fig. 1From: Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signatureThe immune-related lncRNAs model to predict 5-year RFS in breast cancer patients. 1Â HR+/HER2-, 2Â HR+/HER2+, 3Â HR-/HER2+, 4 TNBC, and 5 unknownBack to article page